Cargando…
Adverse Medication Reactions
Cutaneous adverse drug reactions (ADRs) are among the most frequent adverse reactions in patients receiving drug therapy. They have a broad spectrum of clinical manifestations, are caused by various drugs, and result from different pathophysiological mechanisms. Hence, their diagnosis and management...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123512/ http://dx.doi.org/10.1007/978-3-319-29785-9_25 |
_version_ | 1783515653300289536 |
---|---|
author | Dodiuk-Gad, Roni P. Chung, Wen-Hung Shear, Neil H. |
author_facet | Dodiuk-Gad, Roni P. Chung, Wen-Hung Shear, Neil H. |
author_sort | Dodiuk-Gad, Roni P. |
collection | PubMed |
description | Cutaneous adverse drug reactions (ADRs) are among the most frequent adverse reactions in patients receiving drug therapy. They have a broad spectrum of clinical manifestations, are caused by various drugs, and result from different pathophysiological mechanisms. Hence, their diagnosis and management is challenging. Severe cutaneous ADRs comprise a group of diseases with major morbidity and mortality, reaching 30 % mortality rate in cases of Toxic Epidermal Necrolysis. This chapter covers the terminology, epidemiology, pathogenesis and classification of cutaneous ADR, describes the severe cutaneous ADRs and the clinical and laboratory approach to the patient with cutaneous ADR and presents the translation of laboratory-based discoveries on the genetic predisposition and pathogenesis of cutaneous ADRs to clinical management guidelines. |
format | Online Article Text |
id | pubmed-7123512 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71235122020-04-06 Adverse Medication Reactions Dodiuk-Gad, Roni P. Chung, Wen-Hung Shear, Neil H. Clinical and Basic Immunodermatology Article Cutaneous adverse drug reactions (ADRs) are among the most frequent adverse reactions in patients receiving drug therapy. They have a broad spectrum of clinical manifestations, are caused by various drugs, and result from different pathophysiological mechanisms. Hence, their diagnosis and management is challenging. Severe cutaneous ADRs comprise a group of diseases with major morbidity and mortality, reaching 30 % mortality rate in cases of Toxic Epidermal Necrolysis. This chapter covers the terminology, epidemiology, pathogenesis and classification of cutaneous ADR, describes the severe cutaneous ADRs and the clinical and laboratory approach to the patient with cutaneous ADR and presents the translation of laboratory-based discoveries on the genetic predisposition and pathogenesis of cutaneous ADRs to clinical management guidelines. 2017-04-25 /pmc/articles/PMC7123512/ http://dx.doi.org/10.1007/978-3-319-29785-9_25 Text en © Springer International Publishing Switzerland 2017 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Dodiuk-Gad, Roni P. Chung, Wen-Hung Shear, Neil H. Adverse Medication Reactions |
title | Adverse Medication Reactions |
title_full | Adverse Medication Reactions |
title_fullStr | Adverse Medication Reactions |
title_full_unstemmed | Adverse Medication Reactions |
title_short | Adverse Medication Reactions |
title_sort | adverse medication reactions |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123512/ http://dx.doi.org/10.1007/978-3-319-29785-9_25 |
work_keys_str_mv | AT dodiukgadronip adversemedicationreactions AT chungwenhung adversemedicationreactions AT shearneilh adversemedicationreactions |